LTF and COVID-19: This randomized, placebo-controlled, multicenter clinical trial did not show any significant effect of lactoferrin on modifying the clinical evolution and/or laboratory markers of inflammation when used as an add-on treatment in adult patients hospitalized with moderate-to-severe COVID-19.